Global Surgical Robots Market By Component (Systems, Instruments and Accessories, Services), By Mechanism of Control (Computer Control, Direct Telemanipulator), By Application (Orthopedic Surgery, Endometriosis, General Surgery, Neurosurgery, Thoracic Surgery, Colorectal Surgery, Gynecology, Heart Surgery, Urologic Surgery and Others), By End User (Hospitals & Clinics and Ambulatory Surgical Centers), By Region, Competition, Forecast & Opportunities, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 10.49 Billion
CAGR (2026-2031)	15.12%
Fastest Growing Segment	Neurosurgery
Largest Market	North America
Market Size (2031)	USD 24.42 Billion

Market Overview

The Global Surgical Robots Market will grow from USD 10.49 Billion in 2025 to USD 24.42 Billion by 2031 at a 15.12% CAGR. Surgical robots are electromechanical devices that assist surgeons in performing complex procedures with enhanced precision, control, and visualization. The market is primarily propelled by the rising global prevalence of chronic diseases and an aging population that necessitates frequent medical intervention. Furthermore, the growing preference for minimally invasive surgery supports market expansion as these techniques significantly reduce hospital stays, minimize blood loss, and accelerate patient recovery times compared to traditional open surgery methods.

According to the International Federation of Robotics, in 2025, the demand for surgery robots rose by 41% in 2024, reflecting the rapid adoption of this technology within the healthcare sector. Despite this strong trajectory, market expansion faces a significant impediment regarding the high costs associated with robotic systems. The substantial capital investment required for acquisition and maintenance creates a financial barrier that restricts accessibility for smaller healthcare facilities and limits widespread implementation in developing regions.

Key Market Drivers

The surging global demand for minimally invasive surgical procedures is the primary engine driving market expansion, as patients and healthcare providers increasingly prioritize operative techniques that minimize trauma and accelerate recovery. This shift has necessitated the widespread integration of robotic systems, which offer superior dexterity and visualization compared to traditional laparoscopic methods, thereby enabling surgeons to perform complex interventions with greater consistency. The direct correlation between this clinical preference and market performance is evident in recent procedural volumes. According to Intuitive Surgical, October 2024, in the 'Q3 2024 Quarterly Report', worldwide da Vinci procedures grew approximately 18% compared to the third quarter of 2023, reflecting the critical reliance on robotic platforms for general and gynecological surgeries.

Concurrently, rising healthcare expenditure and infrastructure investments are significantly accelerating the development and commercial adoption of these advanced technologies. Hospitals and medical technology firms are channeling substantial capital into upgrading surgical fleets and funding next-generation innovations, such as microsurgical robotics, to address unmet clinical needs. This investment-heavy climate is validating new market entrants and expanding the footprint of established players. According to Medical Microinstruments, February 2024, in a company press release, the firm secured $110 million in Series C financing to support the commercialization of its Symani Surgical System, highlighting strong investor confidence in specialized robotic solutions. Furthermore, established infrastructure is seeing rapid utilization growth; according to Globus Medical, November 2024, in the 'Third Quarter 2024 Earnings Call', revenue from the Enabling Technologies segment rose 39% year-over-year, underscoring the aggressive pace at which facilities are investing in robotic assistance.

Download Free Sample Report

Key Market Challenges

The substantial financial investment required for the acquisition and maintenance of robotic systems stands as a critical impediment to the growth of the Global Surgical Robots Market. Healthcare providers are often hesitant to allocate the necessary funds for these platforms, as the initial purchase price represents only a fraction of the total cost of ownership. The economic burden is further exacerbated by the need for expensive consumable instruments, specialized surgeon training, and ongoing service contracts, which collectively strain hospital budgets. This high barrier to entry disproportionately affects smaller healthcare facilities and institutions in price-sensitive regions, effectively stalling market penetration in these untapped demographics.

This financial strain forces administrators to delay or reject procurement proposals, directly reducing the installation rate of new systems. According to the Royal College of Surgeons of England, in 2024, the capital costs for a robotic surgical system were at least $1.5 million, with additional recurring annual maintenance costs of $100,000. Such significant expenditure requirements limit the market's expansion to wealthy, high-volume centers, preventing manufacturers from scaling operations in broader markets where healthcare spending is more constrained. Consequently, the high total cost of ownership restricts the addressable market size and slows the overall revenue trajectory of the industry.

Key Market Trends

The Proliferation of Compact and Modular Robotic Architectures is altering the market landscape by introducing versatile, small-footprint systems designed for broad laparoscopic application. Unlike legacy mainframe platforms that require dedicated operating rooms, these modular solutions integrate into existing surgical workflows and adapt to varied clinical environments, including space-constrained ambulatory centers. This architectural shift significantly expands the addressable patient population by broadening access to robotic assistance for high-volume soft tissue procedures. According to Moon Surgical, July 2025, in a company press release, the Maestro System has been used to treat over 1,100 patients across general, bariatric, and gynecologic specialties, validating the clinical adoption of these adaptable technologies.

The Integration of Artificial Intelligence and Machine Learning is advancing surgical capabilities through enhanced computing power and data-driven operative insights. New platforms are incorporating substantial processing capacity to support real-time sensing, force feedback, and machine learning algorithms that analyze surgical video to improve decision-making. These systems aim to reduce variability in outcomes by providing surgeons with augmented visual and haptic feedback during complex interventions. According to Intuitive Surgical, January 2025, in the 'Preliminary Fourth Quarter and Full Year 2024 Financial Results', the company placed 362 units of its fifth-generation da Vinci 5 system in 2024, deploying a platform designed with significantly increased computing power to enable these digital functions.

Segmental Insights

The Neurosurgery segment is identified as the fastest growing area within the Global Surgical Robots Market. This growth is driven by the increasing necessity for high precision in delicate brain and spinal procedures, where robotic assistance minimizes risks associated with manual techniques. Market expansion is further supported by approvals from regulatory bodies such as the US Food and Drug Administration (FDA), which validate the safety of these advanced navigation systems. Consequently, healthcare providers are adopting these robotic solutions to facilitate minimally invasive techniques, thereby reducing patient recovery times and improving clinical outcomes for complex neurological conditions.

Regional Insights

North America maintains a dominant position in the global surgical robots market due to the extensive integration of automated technologies within its healthcare facilities. This leadership is supported by a strong concentration of major manufacturers and comprehensive reimbursement frameworks that enable medical centers to invest in robotic systems. Furthermore, the U.S. Food and Drug Administration plays a critical role by granting necessary product approvals, which accelerates market entry for new devices. These elements collectively strengthen the regional market and drive consistent demand for surgical robotics.

Recent Developments

• In October 2024, CMR Surgical secured marketing authorization from the U.S. Food and Drug Administration for its Versius Surgical System. This regulatory milestone established the platform as the first multi-port, soft tissue general surgical robotic device authorized via the De Novo pathway. The system features a modular design with fully wristed instruments and 3D HD vision, intended to offer surgeons enhanced dexterity and ergonomic comfort. The authorization permitted the company to launch the technology in the United States, targeting adult cholecystectomy procedures, and represented a significant expansion of its global commercial footprint in the competitive surgical robotics sector.
• In August 2024, Karl Storz Endoscopy-America, Inc. completed the acquisition of Asensus Surgical, Inc., integrating the digital surgery company as a wholly owned subsidiary. The transaction involved purchasing all outstanding shares for $0.35 per share in cash, resulting in the delisting of the acquired firm's common stock. This strategic move allowed the parent company to strengthen its position in the global surgical robotics market by incorporating advanced digital capabilities and robotic technology. The collaboration aims to accelerate the development and delivery of innovative surgical solutions, including the forthcoming LUNA system, to improve patient outcomes worldwide.
• In May 2024, Sony Group Corporation demonstrated a prototype of a microsurgery assistance robot at an international conference, marking its entry into the surgical robotics space. The system features a unique automatic instrument exchange function and high-precision control capabilities that replicate the delicate movements of a surgeon's fingers on a microscopic scale. Equipped with 4K OLED microdisplays, the robot provides high-definition visualization of tiny tissues such as blood vessels and nerves. The company highlighted that the technology had successfully performed microvascular anastomosis in animal trials, aiming to address the shortage of skilled microsurgeons through advanced robotic assistance.
• In March 2024, Intuitive Surgical announced that it had obtained 510(k) clearance from the U.S. Food and Drug Administration for the da Vinci 5, its fifth-generation multiport robotic system. The platform features force-feedback technology, which allows surgeons to sense the forces exerted on tissue during operations, potentially reducing trauma. Additional enhancements include a high-performance 3D display and increased computing power compared to previous models. The company planned a phased rollout, initially offering the system to select customers in the United States to gather data and optimize the integration of the new technology into hospital workflows.

Key Market Players

• Intuitive Surgical, Inc.
• Medtronic plc
• Stryker Corporation
• Johnson & Johnson
• Zimmer Biomet Holdings, Inc.
• Asensus Surgical, Inc.
• Smith & Nephew plc
• Renishaw plc
• Hansen Medical, Inc.
• CMR Surgical Ltd

By Component	By Mechanism of Control	By Application	By End User	By Region
Systems Instruments and Accessories Services	Computer Control Direct Telemanipulator	Orthopedic Surgery Endometriosis General Surgery Neurosurgery Thoracic Surgery Colorectal Surgery Gynecology Heart Surgery Urologic Surgery and Others	Hospitals & Clinics and Ambulatory Surgical Centers	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Surgical Robots Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Surgical Robots Market, By Component:

• Systems
• Instruments and Accessories
• Services

• Surgical Robots Market, By Mechanism of Control:

• Computer Control
• Direct Telemanipulator

• Surgical Robots Market, By Application:

• Orthopedic Surgery
• Endometriosis
• General Surgery
• Neurosurgery
• Thoracic Surgery
• Colorectal Surgery
• Gynecology
• Heart Surgery
• Urologic Surgery and Others

• Surgical Robots Market, By End User:

• Hospitals & Clinics and Ambulatory Surgical Centers

• Surgical Robots Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE